D.E. Shaw & Co
ACAD icon

D.E. Shaw & Co’s Acadia Pharmaceuticals ACAD Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$42.4M Sell
1,964,521
-384,899
-16% -$8.3M 0.03% 429
2025
Q1
$39M Sell
2,349,420
-891,986
-28% -$14.8M 0.03% 404
2024
Q4
$59.5M Sell
3,241,406
-263,551
-8% -$4.84M 0.04% 319
2024
Q3
$53.9M Buy
3,504,957
+570,031
+19% +$8.77M 0.05% 302
2024
Q2
$47.7M Buy
2,934,926
+292,906
+11% +$4.76M 0.04% 293
2024
Q1
$48.9M Sell
2,642,020
-1,112,578
-30% -$20.6M 0.04% 309
2023
Q4
$118M Sell
3,754,598
-1,034,400
-22% -$32.4M 0.1% 126
2023
Q3
$99.8M Sell
4,788,998
-474,080
-9% -$9.88M 0.1% 123
2023
Q2
$126M Buy
5,263,078
+362,496
+7% +$8.68M 0.13% 110
2023
Q1
$92.2M Buy
4,900,582
+681,183
+16% +$12.8M 0.1% 155
2022
Q4
$67.2M Sell
4,219,399
-492,781
-10% -$7.85M 0.07% 181
2022
Q3
$77.1M Buy
4,712,180
+25,515
+0.5% +$417K 0.09% 157
2022
Q2
$66M Buy
4,686,665
+139,702
+3% +$1.97M 0.08% 207
2022
Q1
$110M Buy
4,546,963
+19,760
+0.4% +$479K 0.1% 147
2021
Q4
$106M Sell
4,527,203
-1,043,329
-19% -$24.4M 0.09% 169
2021
Q3
$92.5M Buy
5,570,532
+805,467
+17% +$13.4M 0.08% 201
2021
Q2
$116M Buy
4,765,065
+2,409,857
+102% +$58.8M 0.1% 167
2021
Q1
$60.8M Buy
2,355,208
+112,408
+5% +$2.9M 0.06% 318
2020
Q4
$120M Sell
2,242,800
-21,713
-1% -$1.16M 0.11% 163
2020
Q3
$93.4M Buy
2,264,513
+116,305
+5% +$4.8M 0.1% 189
2020
Q2
$104M Buy
2,148,208
+858,079
+67% +$41.6M 0.12% 140
2020
Q1
$54.5M Sell
1,290,129
-86,965
-6% -$3.67M 0.09% 211
2019
Q4
$58.9M Sell
1,377,094
-895,290
-39% -$38.3M 0.07% 249
2019
Q3
$81.8M Buy
2,272,384
+370,534
+19% +$13.3M 0.1% 189
2019
Q2
$50.8M Buy
1,901,850
+461,869
+32% +$12.3M 0.06% 298
2019
Q1
$38.7M Buy
1,439,981
+1,290,639
+864% +$34.7M 0.05% 344
2018
Q4
$2.42M Buy
+149,342
New +$2.42M ﹤0.01% 1430
2018
Q3
Sell
-56,267
Closed -$859K 2498
2018
Q2
$859K Buy
+56,267
New +$859K ﹤0.01% 1955
2018
Q1
Hold
0
2478
2017
Q4
Sell
-18,429
Closed -$694K 2496
2017
Q3
$694K Buy
+18,429
New +$694K ﹤0.01% 1947
2017
Q2
Sell
-6,358
Closed -$219K 2386
2017
Q1
$219K Sell
6,358
-45,088
-88% -$1.55M ﹤0.01% 2252
2016
Q4
$1.48M Sell
51,446
-54,437
-51% -$1.57M ﹤0.01% 1583
2016
Q3
$3.37M Buy
105,883
+98,063
+1,254% +$3.12M 0.01% 1128
2016
Q2
$254K Sell
7,820
-20,746
-73% -$674K ﹤0.01% 2306
2016
Q1
$799K Sell
28,566
-36,184
-56% -$1.01M ﹤0.01% 1858
2015
Q4
$2.31M Buy
64,750
+17,974
+38% +$641K ﹤0.01% 1331
2015
Q3
$1.55M Buy
46,776
+1,445
+3% +$47.8K ﹤0.01% 1499
2015
Q2
$1.9M Buy
45,331
+15,882
+54% +$665K ﹤0.01% 1511
2015
Q1
$960K Sell
29,449
-144,752
-83% -$4.72M ﹤0.01% 1765
2014
Q4
$5.53M Buy
174,201
+38,562
+28% +$1.22M 0.01% 886
2014
Q3
$3.36M Buy
135,639
+8,424
+7% +$209K ﹤0.01% 1014
2014
Q2
$2.87M Buy
127,215
+64,251
+102% +$1.45M ﹤0.01% 1113
2014
Q1
$1.53M Sell
62,964
-7,753
-11% -$189K ﹤0.01% 1386
2013
Q4
$1.77M Buy
70,717
+30,913
+78% +$772K ﹤0.01% 1353
2013
Q3
$1.09M Sell
39,804
-57,838
-59% -$1.59M ﹤0.01% 1523
2013
Q2
$1.77M Buy
+97,642
New +$1.77M ﹤0.01% 1272